Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice.
PLoS Pathog. 2024 May 13;20(5):e1011749. doi: 10.1371/journal.ppat.1011749. eCollection 2024 May.
PLoS Pathog. 2024.
PMID: 38739648
Free PMC article.
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1.
Torella L, Klermund J, Bilbao-Arribas M, Tamayo I, Andrieux G, Chmielewski KO, Vales A, Olagüe C, Moreno-Luqui D, Raimondi I, Abad A, Torrens-Baile J, Salido E, Huarte M, Hernaez M, Boerries M, Cathomen T, Zabaleta N, Gonzalez-Aseguinolaza G.
Torella L, et al.
EMBO Mol Med. 2024 Jan;16(1):112-131. doi: 10.1038/s44321-023-00008-8. Epub 2024 Jan 5.
EMBO Mol Med. 2024.
PMID: 38182795
Free PMC article.
Item in Clipboard
Differential Trafficking and Expression of PIR Proteins in Acute and Chronic Plasmodium Infections.
Giorgalli M, Cunningham DA, Broncel M, Sait A, Harrison TE, Hosking C, Vandomme A, Amis SI, Antonello A, Sullivan L, Uwadiae F, Torella L, Higgins MK, Langhorne J.
Giorgalli M, et al. Among authors: torella l.
Front Cell Infect Microbiol. 2022 Jun 16;12:877253. doi: 10.3389/fcimb.2022.877253. eCollection 2022.
Front Cell Infect Microbiol. 2022.
PMID: 35782145
Free PMC article.
Item in Clipboard
mRNA and gene editing: Late breaking therapies in liver diseases.
Zabaleta N, Torella L, Weber ND, Gonzalez-Aseguinolaza G.
Zabaleta N, et al. Among authors: torella l.
Hepatology. 2022 Sep;76(3):869-887. doi: 10.1002/hep.32441. Epub 2022 Apr 1.
Hepatology. 2022.
PMID: 35243655
Free PMC article.
Review.
Item in Clipboard
In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Precise Deletions Using CRISPR-Cas9.
López-Manzaneda S, Ojeda-Pérez I, Zabaleta N, García-Torralba A, Alberquilla O, Torres R, Sánchez-Domínguez R, Torella L, Olivier E, Mountford J, Ramírez JC, Bueren JA, González-Aseguinolaza G, Segovia JC.
López-Manzaneda S, et al. Among authors: torella l.
Mol Ther Methods Clin Dev. 2020 Oct 15;19:426-437. doi: 10.1016/j.omtm.2020.10.007. eCollection 2020 Dec 11.
Mol Ther Methods Clin Dev. 2020.
PMID: 33294491
Free PMC article.
Item in Clipboard
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I.
Zabaleta N, Barberia M, Martin-Higueras C, Zapata-Linares N, Betancor I, Rodriguez S, Martinez-Turrillas R, Torella L, Vales A, Olagüe C, Vilas-Zornoza A, Castro-Labrador L, Lara-Astiaso D, Prosper F, Salido E, Gonzalez-Aseguinolaza G, Rodriguez-Madoz JR.
Zabaleta N, et al. Among authors: torella l.
Nat Commun. 2018 Dec 21;9(1):5454. doi: 10.1038/s41467-018-07827-1.
Nat Commun. 2018.
PMID: 30575740
Free PMC article.
Item in Clipboard
Modelling non-Markovian dynamics in biochemical reactions.
Chiarugi D, Falaschi M, Hermith D, Olarte C, Torella L.
Chiarugi D, et al. Among authors: torella l.
BMC Syst Biol. 2015;9 Suppl 3(Suppl 3):S8. doi: 10.1186/1752-0509-9-S3-S8. Epub 2015 Jun 1.
BMC Syst Biol. 2015.
PMID: 26051249
Free PMC article.
Item in Clipboard
Cite
Cite